Latest News

Recent developments in autism therapies and research from around the world.

June 1, 2026

Growing research interest in the gut-brain connection in autism

Research groups worldwide continue to study links between gut microbiome composition and autism traits, fueling interest in approaches like FMT and targeted probiotics — though most studies remain small and early-stage.

May 18, 2026

More museums, libraries, and public venues add sensory-friendly hours

A growing number of museums, libraries, airports, and community venues are introducing dedicated sensory-friendly hours — dimmed lighting, reduced sound, and lower crowd density — to make public spaces more accessible to autistic visitors. Advocacy groups continue to publish guides for organizations hosting these events, and researchers have called for further participatory input from autistic people themselves in designing sensory-friendly 'zones.'

April 12, 2026

Development continues on earlier and more accessible autism screening tools

Researchers and clinicians continue refining tools meant to flag autism traits earlier, including mobile health apps and AI-assisted approaches such as eye-tracking and video-based classifiers. A recent consensus effort focused on the usability and acceptability of mobile screening tools, while implementation research continues to highlight gaps in provider training and consistent follow-up after a positive screen.

March 28, 2026

Schools continue integrating music therapy into autism support programs

More schools are partnering with music therapists to bring rhythm-based and interactive singing activities into daily programming for autistic students, alongside continued research into music's role in supporting social skills development. Specialized educator training programs, including autism-focused music education concentrations at conservatories, are also expanding to build a pipeline of qualified practitioners.

March 5, 2026

Academic interest grows in photobiomodulation (light-based) therapy for autism

Small open-label studies and registered clinical trials are examining transcranial photobiomodulation — pulsed near-infrared light aimed at the scalp — as a potential way to modulate brain activity in autistic children. Early results report changes in EEG patterns and behavior scores, but researchers caution that studies remain small, mostly uncontrolled, and years away from informing clinical guidelines.

February 10, 2026

MeRT clinic networks continue expanding availability across the U.S.

Private clinic networks offering MeRT (Magnetic e-Resonance Therapy), an individualized EEG-guided form of transcranial magnetic stimulation, continue to open new locations across the U.S., citing demand from families seeking non-drug options for autism. The growth reflects provider-reported demand rather than new independent clinical trial evidence, and families are encouraged to weigh the limited peer-reviewed evidence base before enrolling.

January 20, 2026

Telehealth continues to widen access to speech-language therapy for autistic children

Telepractice delivery of speech-language therapy has continued to grow, particularly for families in rural or underserved areas facing long waitlists for in-person specialists. Reviews of the research suggest telehealth can produce clinical outcomes comparable to in-person sessions for many children, though hybrid models combining remote and in-person visits remain common where feasible.

January 15, 2026

NIH funding landscape for autism research continues to shift

In late 2025 the NIH launched a $50 million Autism Data Science Initiative funding over a dozen projects studying how genetics and environmental exposures interact in autism, following earlier funding cuts affecting autism research across several federal agencies. Advocacy groups continue to track how funding aligns with the priority areas set out in the Autism CARES Act, with most current grants still directed toward basic biology and genetics research.